Industry Session

Tech Forum: Advancing Nucleic Acid Therapeutics: Certest Pharma’s Development of Ionizable Lipids, LNP Platforms, and Targeted Delivery Systems.

Speaker(s)

• JA

  Jesus Aznar Morales, MBA

  Biochemist
  Certest Biotec
• JG

  Javier Giménez-Warren, n/a

  CTO Certest Pharma
  Certest Biotec
  Zaragoza, Spain

In this presentation, we will explore Certest Pharma’s integrated efforts to advance nucleic acid therapeutics through the development of next-generation ionizable lipids, lipid nanoparticle (LNP) platforms, and both passive and active targeting strategies. We will highlight our work in formulation optimization, lyophilization of LNP-based systems, and discuss how our business model supports innovation and collaboration across the RNA therapeutic landscape.